SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Canaccord Genuity initiates Tonix Pharmaceuticals coverage with buy rating, $18 target

Valid market news retained in the public archive without immediate LiveCast distribution.

TNXP

Related stories